Cargando…

Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention

Soft tissue sarcomas (STSs) are a family of rare malignant tumors encompassing more than 80 histologies. Current therapies for metastatic STS, a condition that affects roughly half of patients, have limited efficacy, making innovative therapeutic strategies urgently needed. From a molecular point of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tazzari, Marcella, Bergamaschi, Laura, De Vita, Alessandro, Collini, Paola, Barisella, Marta, Bertolotti, Alessia, Ibrahim, Toni, Pasquali, Sandro, Castelli, Chiara, Vallacchi, Viviana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303572/ https://www.ncbi.nlm.nih.gov/pubmed/34299136 http://dx.doi.org/10.3390/ijms22147518

Ejemplares similares

Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer
por: Camisaschi, Chiara, et al.
Publicado: (2016)

Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma
por: Castelli, Chiara, et al.
Publicado: (2013)

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
por: Recine, Federica, et al.
Publicado: (2017)

Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report
por: Tazzari, Marcella, et al.
Publicado: (2015)

Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived Xenograft
por: Stacchiotti, Silvia, et al.
Publicado: (2019)

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response
por: Vallacchi, Viviana, et al.
Publicado: (2016)

Immune checkpoint inhibitor resistance in soft tissue sarcoma
por: Eulo, Vanessa, et al.
Publicado: (2022)

Genetic susceptibility to bone and soft tissue sarcomas: a field synopsis and meta-analysis
por: Benna, Clara, et al.
Publicado: (2018)

microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy
por: Daveri, Elena, et al.
Publicado: (2020)

Effectiveness of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograft
por: Zuco, Valentina, et al.
Publicado: (2023)

Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin
por: Fabbroni, Chiara, et al.
Publicado: (2021)

PD-L1 assessment in pediatric rhabdomyosarcoma: a pilot study
por: Bertolini, Giulia, et al.
Publicado: (2018)

Comprehensive profiling of immune-related genes in soft tissue sarcoma patients
por: Hu, Chuan, et al.
Publicado: (2020)

Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy
por: Sousa, Luana Madalena, et al.
Publicado: (2021)

Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients
por: Camisaschi, Chiara, et al.
Publicado: (2018)

Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening
por: Fortunato, Orazio, et al.
Publicado: (2022)

Immunization-based scores as independent prognostic predictors in soft tissue sarcoma patients
por: Jiang, Shan-Shan, et al.
Publicado: (2017)

Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma
por: Roszik, Jason, et al.
Publicado: (2021)

Identification of Prognostic lncRNA Related to the Immune Microenvironment of Soft Tissue Sarcoma
por: Dai, Wang-Ying, et al.
Publicado: (2022)

Y(90)-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers
por: Rivoltini, Licia, et al.
Publicado: (2023)

Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
por: De Vita, Alessandro, et al.
Publicado: (2016)

Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma
por: Shen, Rui, et al.
Publicado: (2021)

A novel inflammatory signature for evaluating immune microenvironment status in soft tissue sarcoma
por: Li, Zhehong, et al.
Publicado: (2022)

Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin
por: Fausti, Valentina, et al.
Publicado: (2023)

Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma
por: De Vita, Alessandro, et al.
Publicado: (2016)

The emerging role of cancer nanotechnology in the panorama of sarcoma
por: Mercatali, Laura, et al.
Publicado: (2022)

Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types
por: Tazzari, Marcella, et al.
Publicado: (2018)

Olaratumab’s failure in soft tissue sarcoma
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Pharmacogenomics Biomarkers of Soft Tissue Sarcoma Therapies
por: Caruso, Chiara, et al.
Publicado: (2020)

Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes
por: Klaver, Yarne, et al.
Publicado: (2020)

Characterization of PD-1/PD-L1 immune checkpoint expression in soft tissue sarcomas
por: Hashimoto, Kazuhiko, et al.
Publicado: (2021)

2018 ESMO Sarcoma and GIST Symposium: ‘take-home messages’ in soft tissue sarcoma
por: Frezza, Anna Maria, et al.
Publicado: (2018)

Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents
por: De Vita, Alessandro, et al.
Publicado: (2017)

Staging Systems and Nomograms for Soft Tissue Sarcoma
por: Danieli, Maria, et al.
Publicado: (2023)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Significance of Circulating Tumor Cells in Soft Tissue Sarcoma
por: Nicolazzo, Chiara, et al.
Publicado: (2015)

Correction: Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes
Publicado: (2020)

The construction and analysis of tumor-infiltrating immune cell and ceRNA networks in recurrent soft tissue sarcoma
por: Huang, Runzhi, et al.
Publicado: (2019)

m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma
por: Huang, Zhen-Dong, et al.
Publicado: (2021)

Prognostic attributes of immune signatures in soft tissue sarcomas show differential dependencies on tumor mutational burden
por: Raj, Shailaja K. S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ouibk5tgnp7b06mapl22fu2h0r